Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion

Phase 4 Completed 96 enrolled Prince of Songkla University

RandomizedParallel-groupTriple-blindSupportive care

Summary

The purpose of this study is to evaluate the efficacy of Parecoxib and Ketorolac as a preemptive analgesia in patients undergoing lumbar spinal fusion.

Timeline

Start: 2011-03
Primary completion: 2013-01
Completion: 2013-03

Publications

Siribumrungwong K, Cheewakidakarn J, Tangtrakulwanich B, Nimmaanrat S. Comparing parecoxib and ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion: a prospective randomized double-blinded placebo-controlled trial. BMC Musculoskelet Disord. 2015 Mar 18;16:59. doi: 10.1186/s12891-015-0522-5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketorolac	Other / unclassified	30 mg	Intravenous
Subject	Parecoxib	Small molecule	40 mg	Intravenous

Indications

No indication recorded.